The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: endometrial cancer

Trends in 2009: Personalized Medicine and Cancer Update

The Boston Globe reported this week on current trends in genetic testing of tumors:

  • Massachusetts General Hospital will be adding $2,000 per patient worth of genetic testing as part of its standard of care for cancer.
  • Dana-Farber tests selected patients, including patients with certain melanomas, where doctors know those malignancies can carry abnormalities that are susceptible to certain drugs.
  • Memorial Sloan-Kettering Cancer Center in New York, will start screening most patients with lung cancer within weeks.

This week has seen some scientific developments reported in tumor screening as well:

  • A study in PNAS reports on an analysis of genome-wide expression and copy-number data in endometrial cancers and finds a couple of prognostically-relevant results.
  • A study in the Journal of Clinical Oncology reports on the use of a 50 gene array to successfully identify four breast cancer tumor types that have been previously defined: luminal A, luminal B, HER2-enriched and basal-like.

We’ll see if the accumulation of data is sufficient to make a case for insurance coverage.

Bookmark and Share

Follow

Get every new post delivered to your Inbox.

Join 126 other followers